(Q37336868)

19 August 2017

1 reference

title

Dendritic cells in the skin--potential use for melanoma treatment (English)

1 reference

19 August 2017

Sanaa El Marsafy

1

1 reference

19 August 2017

Martine Bagot

series ordinal

2

1 reference

19 August 2017

Armand Bensussan

series ordinal

3

1 reference

19 August 2017

Alain Mauviel

series ordinal

4

1 reference

19 August 2017

27 November 2008

1 reference

Pigment Cell & Melanoma Research

19 August 2017

1 reference

19 August 2017

22

1 reference

19 August 2017

1

1 reference

19 August 2017

30-41

1 reference

Interaction of TNF with TNF receptor type 2 promotes expansion and function of mouse CD4+CD25+ T regulatory cells.

19 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2008.00532.X

Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2008.00532.X

Metastatic melanoma secreted IL-10 down-regulates CD1 molecules on dendritic cells in metastatic tumor lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2008.00532.X

Tumor-derived TGFbeta-1 induces dendritic cell apoptosis in the sentinel lymph node.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2008.00532.X

Cutting edge: induction of B7-H4 on APCs through IL-10: novel suppressive mode for regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2008.00532.X

Elevated TGF-beta1 secretion and down-modulation of NKG2D underlies impaired NK cytotoxicity in cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2008.00532.X

The critical role of IL-15 in the antitumor effects mediated by the combination therapy imatinib and IL-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2008.00532.X

Administration of a CD25-directed immunotoxin, LMB-2, to patients with metastatic melanoma induces a selective partial reduction in regulatory T cells in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2008.00532.X

Flt3-ligand and granulocyte colony-stimulating factor mobilize distinct human dendritic cell subsets in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2008.00532.X

Granulocyte-Macrophage Colony-Stimulating Factor-Based Melanoma Cell Vaccines Immunize Syngeneic and Allogeneic Recipients via Host Dendritic Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2008.00532.X

21 January 2018

T-cell clonal anergy.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2008.00532.X

Narrow excision (1-cm margin). A safe procedure for thin cutaneous melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2008.00532.X

Activation of Dendritic Cells That Cross-Present Tumor-Derived Antigen Licenses CD8+ CTL to Cause Tumor Eradication

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2008.00532.X

IDO expression by dendritic cells: tolerance and tryptophan catabolism

21 January 2018

1 reference

31 May 2024

https://opencitations.net/index/api/v1/citations/10.1038/NRI1457

Identifiers

DOI

10.1111/J.1755-148X.2008.00532.X

1 reference

19 August 2017

1 reference